{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:07:00Z","timestamp":1793020020651,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study aimed to compare clinical and radiological differences of ONFH patients who were treated with denosumab, and a control group. A total of 178 patients (272 hips) with symptomatic, nontraumatic ONFH were divided into a denosumab group (98 patients, 146 hips) and a control group (80 patients, 126 hips). Patients in the denosumab group received a 60\u00a0mg subcutaneous dose of denosumab every 6\u00a0months. For the clinical assessments, Harris hip scores (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were evaluated. Plain radiographs and MRI were performed before and a minimum of 1\u00a0year after administration of denosumab, which were evaluated for radiological results including femoral head collapse (\u2265\u20092\u00a0mm) and volume change of necrotic lesion. Femoral head collapse occurred in 36 hips (24.7%) in the denosumab group, and 48 hips (38.1%) in the control group, which was statistically significant (<jats:italic>P<\/jats:italic>\u2009=\u20090.012). Twenty-three hips (15.8%) in the denosumab group and 29 hips (23%) in the control group required THA, which showed no significant difference (<jats:italic>P<\/jats:italic>\u2009=\u20090.086). At the final follow-up, 71.9% of hips in the denosumab group had a good or excellent HHS compared with 48.9% in the control group, showing a significant difference (<jats:italic>P<\/jats:italic>\u2009=\u20090.012). The denosumab group showed a significantly higher rate of necrotic lesion volume reductions compared with the control group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Denosumab can significantly reduce the volume of necrotic lesions and prevent femoral head collapse in patients with ARCO stage I or II ONFH.<\/jats:p>","DOI":"10.1038\/s41598-024-54685-7","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T03:02:25Z","timestamp":1708398145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The efficacy of Denosumab in the treatment of femoral head osteonecrosis: a retrospective comparative study"],"prefix":"10.1038","volume":"14","author":[{"given":"Jun-Ki","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisack","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Youn","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Whan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"54685_CR1","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.arth.2020.02.067","volume":"35","author":"N Sodhi","year":"2020","unstructured":"Sodhi, N. et al. Thirty-day complications in osteonecrosis patients following total hip arthroplasty. J. Arthroplasty 35, 2136\u20132143 (2020).","journal-title":"J. Arthroplasty"},{"key":"54685_CR2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1302\/0301-620X.99B10.BJJ-2017-0233.R2","volume":"99","author":"M Chughtai","year":"2017","unstructured":"Chughtai, M. et al. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Jt. J. 99, 1267\u20131279 (2017).","journal-title":"Bone Jt. J."},{"key":"54685_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1302\/2058-5241.4.180036","volume":"4","author":"D Petek","year":"2019","unstructured":"Petek, D., Hannouche, D. & Suva, D. Osteonecrosis of the femoral head: Pathophysiology and current concepts of treatment. EFORT Open Rev. 4, 85\u201397 (2019).","journal-title":"EFORT Open Rev."},{"key":"54685_CR4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00402-020-03364-z","volume":"140","author":"JK Moon","year":"2020","unstructured":"Moon, J. K. et al. Multiple drilling and multiple matchstick-like bone allografts for large osteonecrotic lesions in the femoral head: An average 3-year follow-up study. Arch. Orthop. Trauma Surg. 140, 1655\u20131663 (2020).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"54685_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13018-019-1359-7","volume":"14","author":"KC Hua","year":"2019","unstructured":"Hua, K. C. et al. The efficacy and safety of core decompression for the treatment of femoral head necrosis: A systematic review and meta-analysis. J. Orthop. Surg. Res. 14, 306 (2019).","journal-title":"J. Orthop. Surg. Res."},{"key":"54685_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4055\/cios.2019.11.2.137","volume":"11","author":"YK Lee","year":"2019","unstructured":"Lee, Y. K., Lee, B., Parvizi, J., Ha, Y. C. & Koo, K. H. Which osteotomy for osteonecrosis of the femoral head and which patient for the osteotomy? Clin. Orthop. Surg. 11, 137\u2013141 (2019).","journal-title":"Clin. Orthop. Surg."},{"key":"54685_CR7","doi-asserted-by":"publisher","first-page":"e0156903","DOI":"10.1371\/journal.pone.0156903","volume":"11","author":"W Zuo","year":"2016","unstructured":"Zuo, W. et al. Investigating clinical failure of bone grafting through a window at the femoral head neck junction surgery for the treatment of osteonecrosis of the femoral head. PLoS ONE 11, e0156903 (2016).","journal-title":"PLoS ONE"},{"key":"54685_CR8","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2106\/JBJS.N.01157","volume":"97","author":"YK Lee","year":"2015","unstructured":"Lee, Y. K. et al. Does zoledronate prevent femoral head collapse from osteonecrosis? A prospective, randomized, open-label, multicenter study. J. Bone Jt. Surg. Am. 97, 1142\u20131148 (2015).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"54685_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1302\/2046-3758.59.2000500","volume":"5","author":"Z Yang","year":"2016","unstructured":"Yang, Z. et al. The efficacy of statins in preventing glucocorticoid-related osteonecrosis in animal models: A meta-analysis. Bone Jt. Res. 5, 393\u2013402 (2016).","journal-title":"Bone Jt. Res."},{"key":"54685_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12891-016-1199-0","volume":"17","author":"H Yin","year":"2016","unstructured":"Yin, H., Yuan, Z. & Wang, D. Multiple drilling combined with simvastatin versus multiple drilling alone for the treatment of avascular osteonecrosis of the femoral head: A 3-year follow-up study. BMC Musculoskelet. Disord. 17, 344 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"54685_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41598-018-19884-z","volume":"8","author":"D Li","year":"2018","unstructured":"Li, D., Yang, Z., Wei, Z. & Kang, P. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: A PRISMA-compliant meta-analysis of animal studies and clinical trials. Sci. Rep. 8, 1450 (2018).","journal-title":"Sci. Rep."},{"key":"54685_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jbspin.2007.12.008","volume":"75","author":"K Pengde","year":"2008","unstructured":"Pengde, K., Fuxing, P., Bin, S., Jing, Y. & Jingqiu, C. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Jt. Bone Spine 75, 696\u2013701 (2008).","journal-title":"Jt. Bone Spine"},{"key":"54685_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik, P. J. et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J. Bone Miner. Res. 24, 182\u2013195 (2009).","journal-title":"J. Bone Miner. Res."},{"key":"54685_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14712598.2022.2022118","volume":"22","author":"B Huzum","year":"2022","unstructured":"Huzum, B., Antoniu, S. & Dragomir, R. Treatment of fibrous dysplasia: Focus on denosumab. Expert Opin. Biol. Ther. 22, 397\u2013405 (2022).","journal-title":"Expert Opin. Biol. Ther."},{"key":"54685_CR15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce, A. M. et al. Denosumab treatment for fibrous dysplasia. J. Bone Miner. Res. 27, 1462\u20131470 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"54685_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm7120479","volume":"7","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi, T. et al. Efficacy and safety of denosumab therapy for osteogenesis imperfecta patients with osteoporosis-case series. J. Clin. Med. 7, 12 (2018).","journal-title":"J. Clin. Med."},{"key":"54685_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/17453674.2017.1298020","volume":"88","author":"AL Meiss","year":"2017","unstructured":"Meiss, A. L., Barvencik, F., Babin, K. & Eggers-Stroeder, G. Denosumab and surgery for the treatment of Perthes\u2019 disease in a 9-year-old boy: Favorable course documented by comprehensive imaging\u2014A case report. Acta Orthop. 88, 354\u2013357 (2017).","journal-title":"Acta Orthop."},{"key":"54685_CR18","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1359\/jbmr.060905","volume":"21","author":"HK Kim","year":"2006","unstructured":"Kim, H. K., Morgan-Bagley, S. & Kostenuik, P. RANKL inhibition: A novel strategy to decrease femoral head deformity after ischemic osteonecrosis. J. Bone Miner. Res. 21, 1946\u20131954 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"54685_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.arth.2019.11.029","volume":"35","author":"BH Yoon","year":"2020","unstructured":"Yoon, B. H. et al. The 2019 revised version of association research circulation osseous staging system of osteonecrosis of the femoral head. J. Arthroplasty 35, 933\u2013940 (2020).","journal-title":"J. Arthroplasty"},{"key":"54685_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/os.13584","volume":"15","author":"B Liu","year":"2023","unstructured":"Liu, B., Gao, F., Xiu, X., Wu, T. & Liu, Z. Denosumab can prevent collapse in patients with early-stage steroid-induced osteonecrosis of the femoral head by inhibiting osteoclasts and autophagy. Orthop. Surg. 15, 256\u2013265 (2023).","journal-title":"Orthop. Surg."},{"key":"54685_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00264-013-1775-y","volume":"37","author":"JS Kang","year":"2013","unstructured":"Kang, J. S., Moon, K. H., Kwon, D. G., Shin, B. K. & Woo, M. S. The natural history of asymptomatic osteonecrosis of the femoral head. Int. Orthop. 37, 379\u2013384 (2013).","journal-title":"Int. Orthop."},{"key":"54685_CR22","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1038\/s41598-017-10817-w","volume":"7","author":"A Narayanan","year":"2017","unstructured":"Narayanan, A. et al. Avascular necrosis of femoral head: A metabolomic, biophysical, biochemical, electron microscopic and histopathological characterization. Sci. Rep. 7, 10721 (2017).","journal-title":"Sci. Rep."},{"key":"54685_CR23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jbmr.4006","volume":"35","author":"DW Dempster","year":"2020","unstructured":"Dempster, D. W. et al. Modeling-based bone formation in the human femoral neck in subjects treated with denosumab. J. Bone Miner. Res. 35, 1282\u20131288 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"54685_CR24","doi-asserted-by":"publisher","first-page":"115850","DOI":"10.1016\/j.bone.2021.115850","volume":"145","author":"PR Jensen","year":"2021","unstructured":"Jensen, P. R., Andersen, T. L., Chavassieux, P., Roux, J. P. & Delaisse, J. M. Bisphosphonates impair the onset of bone formation at remodeling sites. Bone 145, 115850 (2021).","journal-title":"Bone"},{"key":"54685_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s13018-021-02875-8","volume":"16","author":"JH Bahk","year":"2021","unstructured":"Bahk, J. H., Jo, W. L., Kim, S. C., Kwon, S. Y. & Lim, Y. W. Lateral pillar is the key in supporting pre-collapse osteonecrosis of the femoral head: A finite element model analysis of propensity-score matched cohorts. J. Orthop. Surg. Res. 16, 728 (2021).","journal-title":"J. Orthop. Surg. Res."},{"key":"54685_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arth.2019.05.039","volume":"35","author":"KN Hindoyan","year":"2020","unstructured":"Hindoyan, K. N., Lieberman, J. R., Matcuk, G. R. & White, E. A. A precise and reliable method of determining lesion size in osteonecrosis of the femoral head using volumes. J. Arthroplasty 35, 285\u2013290 (2020).","journal-title":"J. Arthroplasty"},{"key":"54685_CR27","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00264-018-3912-0","volume":"42","author":"ME Steinberg","year":"2018","unstructured":"Steinberg, M. E., Oh, S. C., Khoury, V., Udupa, J. K. & Steinberg, D. R. Lesion size measurement in femoral head necrosis. Int. Orthop. 42, 1585\u20131591 (2018).","journal-title":"Int. Orthop."},{"key":"54685_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5371\/hp.2015.27.3.125","volume":"27","author":"SJ Lim","year":"2015","unstructured":"Lim, S. J. & Park, Y. S. Plain radiography of the hip: A review of radiographic techniques and image features. Hip Pelvis 27, 125\u2013134 (2015).","journal-title":"Hip Pelvis"},{"key":"54685_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00264-009-0829-7","volume":"34","author":"FC Zhao","year":"2010","unstructured":"Zhao, F. C., Li, Z. R. & Zhang, N. F. Lesion size changes in osteonecrosis of the femoral head: A long-term prospective study using MRI. Int. Orthop. 34, 799\u2013804 (2010).","journal-title":"Int. Orthop."},{"key":"54685_CR30","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1302\/0301-620X.91B8.21518","volume":"91","author":"S Agarwala","year":"2009","unstructured":"Agarwala, S., Shah, A. & Joshi, V. R. The use of alendronate in the treatment of avascular necrosis of the femoral head: Follow-up to eight years. J. Bone Jt. Surg. Br. 91, 1013\u20131018 (2009).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"54685_CR31","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/art.33498","volume":"64","author":"CH Chen","year":"2012","unstructured":"Chen, C. H. et al. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 64, 1572\u20131578 (2012).","journal-title":"Arthritis Rheum."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54685-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T06:02:56Z","timestamp":1708668176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-54685-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4140"}}